Crucell (CRXLY) Company Profile
Last Updated by Anonymous | Update This Page Now
![Crucell (CRXLY) Company Profile Logo](https://wikiwealth.wdfiles.com/local--resized-images/profile:crxly/size="small"/medium.jpg)
General Information
Name:
Website:
Phone: n/a
Email: n/a
Founded: n/a
Employees: n/a
Stage: Seed (just an idea)
Location:
Address:
n/a
Industry / Market
Target:
Products: n/a
Size: n/a
Growth Rate: n/a%
Other Info: n/a
Management Team
Multi-Media
Web Presence
n/a
Images:
Documents:
Videos:
Crucell N.V. is a biopharmaceutical company focused on developing and producing products to combat infectious diseases in three distinct areas: pediatric, travel and endemic, and respiratory. Crucells product development programs include vaccines against yellow fever, influenza, human immunodeficiency virus (HIV), malaria, tuberculosis, human monoclonal antibodies against rabies, H5N1 antibodies, pandemic influenza virus, as well as blood coagulation factors. (see report summary)
Management Analysis
has a consistent company strategy. Big strategy changes can be disruptive, which could hurt long term value.
Post preview:
Close preview